[Delayed]Takara Bio Announces Transfer of SAKIGAKE and Orphan Designations for NY-ESO-1/siTCR Gene Therapy Product
[Delayed]Takara Bio Announces Transfer of SAKIGAKE and Orphan Designations for NY-ESO-1/siTCR Gene Therapy Product | IR News | News Release ＆ IR News | Investor Relations Read more
Danaher Reports Fourth Quarter and Full Year 2022 Results
WASHINGTON, Jan. 24, 2023 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the fourth quarter and full year 2022. All results in this release reflect only continuing operations unless otherwise noted. Net earnings refers to net earnings attributable to common shareholders. For the quarter ended December 31, 2022, net earnings were... Read more
MKS Instruments Announces Fourth Quarter and Full Year 2022 Earnings Conference Call
ANDOVER, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release fourth quarter and full year 2022 financial results after market close on Monday, February 13, Read more